electroCore (ECOR) Short term Debt (2017 - 2026)
electroCore (ECOR) recorded quarterly Short term Debt of $250000.0 in Q1 2026, down 88.84% quarter-over-quarter from $2.2 million in Q4 2017.
electroCore (ECOR) Short term Debt (2017 - 2026) Analysis & Trends
electroCore's Short term Debt history runs 2 years deep, the most recent figure standing at $250000.0 for Q1 2026.
- In Q1 2026, Short term Debt changed N/A year-over-year to $250000.0; the TTM figure through Mar 2026 stood at $250000.0 (changed N/A YoY), while the FY2017 annual figure was $2.2 million, changed N/A from the prior year.
- Short term Debt was $250000.0 for Q1 2026 at electroCore, down from $2.2 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $250000.0 in Q1 2026 to a low of $250000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | electroCore | 75,742.38 | -8.80 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 250,000.00 |
| Dec 31, 2017 | 2.24 Mn |